Generic Drugs
-
{
- All
- News
- Videos
-
Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?
Patent expiry does not signal a change in the medicine itself. Rather, it marks the beginning of wider competition, which typically leads to price reductions and improved availability.
-
Ozempic Revolution In India? Semaglutide Patent Expiry Sparks Generic Rush: Report
As the patent for semaglutide, the active ingredient in Ozempic, nears expiry, Indian pharmaceutical companies are preparing to launch cheaper generic versions.
-
Trump May Exclude Generic Drugs From Tariffs. Good News For India?
The Donald Trump administration has dropped plans to impose tariffs on generic drugs from foreign countries, following months of debate over whether to impose taxes on the majority of medications prescribed in the US.
-
Mandatory Prescription Of Generic Drugs Rule Put On Hold By Medical Panel
The National Medical Commission (NMC) on Thursday put on hold the regulations that make it mandatory for doctors to prescribe generic drugs and bar them from accepting gifts from pharma companies or endorsing any drug brands.
-
Defer Implementation Of Rules On Generic Drugs: Doctors' Body To Government
The Indian Medical Association (IMA) on Monday demanded that implementation of regulations that make it mandatory for doctors to prescribe generic drugs be deferred, raising concerns over the standard of drugs manufactured i
-
Doctors To Be Penalised For Failing To Prescribe Generic Drugs, Say Rules
All doctors must prescribe generic drugs, failing which they will be penalised and even their license to practice may also be suspended for a period, according to the new regulations issued by the National Medical Commission.
-
Hyderabad-Based Hetero Prices Generic COVID-19 Drug At Rs 5,400 Per Vial
Hyderabad-based Hetero Labs Ltd has priced its generic version of remdesivir, Gilead's experimental COVID-19 drug, at Rs 5,400 ($71) per 100-milligram vial, the drug maker said on Wednesday, as it prepares to ship them to hospitals in the country.
-
Generic Drugs Result In Rs 2,000 Crore Benefits For Common People: Centre
The government Tuesday said that generic drugs have resulted in benefits worth Rs 2,000 crore for common people.
-
Generic Versus Branded Medicines: Quick Facts for Consumers
Before the pros and cons of the directive can be studied in its microcosm, it is imperative to understand the very basics.
-
PM Narendra Modi Hints At Rules For Doctors To Prescribe Generic Drugs
Prime Minister Narendra Modi today indicated that his government may bring in a legal framework under which doctors will have to prescribe generic medicines, which are cheaper than equivalent branded drugs, to patients. PM Modi said his government brought in a health policy after 15 years and capped the prices of medicines and stents, which has ang...
-
Unease grows among US doctors over quality of Indian medicines
Some US doctors are becoming concerned about the quality of generic drugs supplied by Indian manufacturers following a flurry of recalls and import bans by the Food and Drug Administration (FDA).
-
Patent board rules against Bayer in cancer drug case
A patent appeals board upheld on Monday a decision to allow a domestic company to sell a generic version of Bayer AG's cancer drug Nexavar, in a blow for global drugmakers' efforts to hold on to monopolies on high-price medicines.
-
Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?
Patent expiry does not signal a change in the medicine itself. Rather, it marks the beginning of wider competition, which typically leads to price reductions and improved availability.
-
Ozempic Revolution In India? Semaglutide Patent Expiry Sparks Generic Rush: Report
As the patent for semaglutide, the active ingredient in Ozempic, nears expiry, Indian pharmaceutical companies are preparing to launch cheaper generic versions.
-
Trump May Exclude Generic Drugs From Tariffs. Good News For India?
The Donald Trump administration has dropped plans to impose tariffs on generic drugs from foreign countries, following months of debate over whether to impose taxes on the majority of medications prescribed in the US.
-
Mandatory Prescription Of Generic Drugs Rule Put On Hold By Medical Panel
The National Medical Commission (NMC) on Thursday put on hold the regulations that make it mandatory for doctors to prescribe generic drugs and bar them from accepting gifts from pharma companies or endorsing any drug brands.
-
Defer Implementation Of Rules On Generic Drugs: Doctors' Body To Government
The Indian Medical Association (IMA) on Monday demanded that implementation of regulations that make it mandatory for doctors to prescribe generic drugs be deferred, raising concerns over the standard of drugs manufactured i
-
Doctors To Be Penalised For Failing To Prescribe Generic Drugs, Say Rules
All doctors must prescribe generic drugs, failing which they will be penalised and even their license to practice may also be suspended for a period, according to the new regulations issued by the National Medical Commission.
-
Hyderabad-Based Hetero Prices Generic COVID-19 Drug At Rs 5,400 Per Vial
Hyderabad-based Hetero Labs Ltd has priced its generic version of remdesivir, Gilead's experimental COVID-19 drug, at Rs 5,400 ($71) per 100-milligram vial, the drug maker said on Wednesday, as it prepares to ship them to hospitals in the country.
-
Generic Drugs Result In Rs 2,000 Crore Benefits For Common People: Centre
The government Tuesday said that generic drugs have resulted in benefits worth Rs 2,000 crore for common people.
-
Generic Versus Branded Medicines: Quick Facts for Consumers
Before the pros and cons of the directive can be studied in its microcosm, it is imperative to understand the very basics.
-
PM Narendra Modi Hints At Rules For Doctors To Prescribe Generic Drugs
Prime Minister Narendra Modi today indicated that his government may bring in a legal framework under which doctors will have to prescribe generic medicines, which are cheaper than equivalent branded drugs, to patients. PM Modi said his government brought in a health policy after 15 years and capped the prices of medicines and stents, which has ang...
-
Unease grows among US doctors over quality of Indian medicines
Some US doctors are becoming concerned about the quality of generic drugs supplied by Indian manufacturers following a flurry of recalls and import bans by the Food and Drug Administration (FDA).
-
Patent board rules against Bayer in cancer drug case
A patent appeals board upheld on Monday a decision to allow a domestic company to sell a generic version of Bayer AG's cancer drug Nexavar, in a blow for global drugmakers' efforts to hold on to monopolies on high-price medicines.
